Ananta Khurana Selected Research

Ananta Khurana Research Topics

Disease

11	Tinea (Ringworm) 11/2022 - 01/2018
7	Infections 11/2022 - 07/2015
4	COVID-19 03/2022 - 07/2020
4	Erythema Nodosum 10/2021 - 04/2020
3	Alopecia Areata 04/2022 - 01/2020
3	Leprosy (Hansen's Disease) 10/2021 - 04/2020
3	Acne Vulgaris 05/2021 - 07/2020
2	Vitiligo 01/2021 - 02/2019
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 02/2019
1	Angiolymphoid Hyperplasia with Eosinophilia 11/2022
1	Scabies (Sarcoptic Mange) 03/2022
1	Granuloma 01/2022
1	Pemphigus (Pemphigus Vulgaris) 01/2022
1	Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis) 10/2021
1	Neoplasms (Cancer) 07/2021
1	Drug Hypersensitivity Syndrome 03/2021
1	Pyogenic Granuloma 01/2021
1	Hyperandrogenism 11/2020
1	Exfoliative Dermatitis (Erythroderma) 11/2020
1	Sleep Deprivation 07/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 07/2020
1	Tinea cruris 07/2020
1	Erythema Multiforme 04/2020
1	Lepromatous Leprosy 04/2020
1	Exanthema (Rash) 01/2020
1	Mycoses (Diseases, Fungus) 11/2018
1	Lymphangioma (Cavernous Lymphangioma) 10/2018
1	Atopic Dermatitis (Atopic Eczema) 09/2015
1	Skin Diseases (Skin Disease) 10/2014
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2014
1	Syphilis 07/2014
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2014
1	Behcet Syndrome (Behcet's Syndrome) 03/2014
1	Lichen Planus (Lichen Ruber Planus) 03/2014
1	Hidradenitis Suppurativa 03/2014
1	Pyoderma Gangrenosum 03/2014
1	Lichen Sclerosus et Atrophicus (Lichen Sclerosus) 03/2014
1	Blister (Bulla) 11/2013

Drug/Important Bio-Agent (IBA)

8	Terbinafine (Lamisil)FDA LinkGeneric 11/2022 - 01/2018
7	SteroidsIBA 01/2022 - 01/2020
7	Pharmaceutical PreparationsIBA 12/2021 - 03/2014
6	Itraconazole (Sporanox)FDA LinkGeneric 11/2022 - 01/2018
3	Methotrexate (Mexate)FDA LinkGeneric 03/2022 - 02/2021
2	Thalidomide (Thalomid)FDA Link 11/2022 - 10/2021
2	AntioxidantsIBA 04/2022 - 01/2021
2	Superoxide DismutaseIBA 04/2022 - 01/2021
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 03/2022 - 11/2020
2	Rifampin (Rifampicin)FDA LinkGeneric 10/2021 - 04/2020
2	Interleukin-17 (Interleukin 17)IBA 05/2021 - 02/2019
2	Immunosuppressive Agents (Immunosuppressants)IBA 02/2021 - 07/2020
2	Squalene Monooxygenase (Squalene Epoxidase)IBA 01/2021 - 12/2018
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 10/2018
2	Hormones (Hormone)IBA 11/2020 - 07/2020
2	AndrogensIBA 11/2020 - 07/2020
2	Anti-Mullerian HormoneIBA 11/2020 - 07/2020
2	CytokinesIBA 01/2020 - 02/2019
1	Voriconazole (Vfend)FDA LinkGeneric 11/2022
1	AldehydesIBA 04/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Leflunomide (Arava)FDA LinkGeneric 01/2022
1	Polidocanol (Laureth)FDA Link 01/2022
1	Anthralin (Dithranol)IBA 01/2022
1	Griseofulvin (Grifulvin V)FDA LinkGeneric 12/2021
1	Fluconazole (Zonal)FDA LinkGeneric 12/2021
1	Antiparasitic Agents (Antiparasitics)IBA 07/2021
1	Ivermectin (Mectizan)FDA Link 07/2021
1	hydroxide ionIBA 05/2021
1	Calcifediol (Calcidiol)FDA Link 05/2021
1	Vitamin D FDA LinkGeneric 05/2021
1	Trimetazidine (Vastarel)IBA 03/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2021
1	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 01/2021
1	Glutathione (Reduced Glutathione)IBA 01/2021
1	Malondialdehyde (Propanedial)IBA 01/2021
1	17-alpha-Hydroxyprogesterone (17 Hydroxyprogesterone)IBA 11/2020
1	Follicle Stimulating Hormone (Follitropin)FDA Link 11/2020
1	Sex Hormone-Binding GlobulinIBA 11/2020
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 11/2020
1	Testosterone (Sustanon)FDA Link 11/2020
1	Dehydroepiandrosterone SulfateIBA 11/2020
1	Sunscreening Agents (Sunscreens)IBA 07/2020
1	CosmeticsIBA 07/2020
1	AutoantigensIBA 01/2020
1	Drug CombinationsIBA 01/2020
1	Interleukin-2 (IL2)IBA 02/2019
1	Interleukin-22 (IL-22)IBA 02/2019
1	ImmunosorbentsIBA 02/2019
1	EnzymesIBA 02/2019
1	AllylamineIBA 07/2018
1	Immunoglobulin E (IgE)IBA 09/2015
1	GlobulinsIBA 07/2015
1	Immunologic Factors (Immunomodulators)IBA 07/2015
1	Penicillins (Penicillin)FDA Link 07/2014
1	Immunoglobulin M (IgM)IBA 11/2013
1	Immunoglobulin G (IgG)IBA 11/2013

Therapy/Procedure

3	Sclerotherapy 01/2022 - 07/2012
3	Therapeutics 04/2020 - 10/2014
1	Length of Stay 02/2021
1	Duration of Therapy 07/2020
1	Radiofrequency Ablation 10/2018